CI

At a glance

ClinicalIndex Comparison Record
N/ATerminated· 250 target
Drug / intervention
Cypher, Taxus or Endeavordevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00592228
NCT00592228N/ATerminated
Terminated
CompareCT.gov

Deferral of Angioplasty According to Fractional Flow Reserve vs. Routine Drug-eluting Stent Implantation in Intermediate Coronary Stenosis

Seoul National University Hospital·interventional·Posted Jan 11, 2008·Updated Dec 21, 2010

In Brief

A clinical study evaluating Cypher, Taxus or Endeavor for Coronary Angiography and 2 related conditions. Terminated early, enrolled 250 participants across 1 site.

Signals

Trial was terminated early

Detailed Summary

Angiographic evaluation for intermediate lesions is not always accurate. Fractional flow reserve-guided deferral strategy for these lesions showed the same event rate as routine intervention strategy. However, proper FFR criterion for these lesions in the era of drug-eluting stent is not known. This study sought to evaluate the clinical outcomes of intermediate lesions according to FFR and compare those of FFR-guided intervention with routine drug-eluting stent implantation strategy.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCoronary Angiography, Drug-eluting Stents, Fractional Flow Reserve, Myocardial
CountriesSouth Korea
Collaborators--

Timeline

N/ATerminatedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJan 11, 2008
Enrollment StartJan 1, 2007
Primary CompletionJan 1, 2009
TodayJul 1, 2026
Enrollment to primary: 2 yearsPosted 18.5 years ago

Interventions

Cypher, Taxus or Endeavordevice

percutaneous drug-eluting stent implantation, 1. FFR group: if FFR\<0.75 2. Routine DES group